The work of Ingelsl represents a serious effort to grapple with the difficult problem of accurately assessing regional left ventricular wall motion. Since the left ventricular wall motion myocardial markers were used as a standard of segmental wall motion, the evaluation of the five methods of wall motion assessment is dependent on the reliability of that standard. I wonder if midmyocardial markers truly reflect endocardial position at end-systole. An echocardiogram showing vigorous posterior left ventricular wall thickening in systole suggests that endocardial and epicardial motion are not necessarily similar. Where along the gradient of motion would one find the midmyocardial marker?
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Another potential problem with discrete markers aligned in a plane is the inability to distinguish rotational motion from truly contraction generated inward motion. For example, take a cut-out of figure 1 and place pinholes as markers in the manner indicated in that diagram. Shine a bright light toward the silhouette and note the shadows cast on a paper below when the silhouette plane is parallel to the paper on which the shadow is cast. Now rotate the silhouette and note the marker locations on the paper below. The markers appear to have moved inward. The analogy is clear. Rotational motion of the ventricle about its long axis could give an illusion of contraction where none had occurred. If the heart rotates about the long axis, this should be seen in the left anterior oblique projection. Have these investigators viewed the marker placement at systole and diastole in the left anterior oblique view to assess rotation of the markers versus inward contractile motion? The authors reply: To the Editor: We appreciate Dr. Gelbert's thoughtful comments regarding our recent paper and are happy to respond to his questions.
(1) In the presence of significant systolic wall thickening do midmyocardial markers truly reflect the motion of adjacent endocardial sites in the two-dimensional right anterior oblique plane?
(2) Does three-dimensional cardiac rotation introduce an important artifact giving an illusion of contraction where none has occurred?
To answer the first question we must differentiate between two different types of motion which we might measure: ventricular wall motion (from epicardium to endocardium) and the motion of the border of the ventricular cavity as defined by contrast angiography or echocardiography. Measurement of dye or echo border dynamics cannot be used to completely specify ventricular wall motion because: (1) the intervening trabeculations and other endocardial irregularities uncouple the two in a nonlinear, time varying manner which we cannot measure and (2) dye or echo borders do not identify specific sites fixed in the myocardium.
In our study we defined left ventricular wall motion as the dynamics of specific midwall markers in the 300 RAO plane. Given this definition, our results showed that this wall motion was best measured using a fixed external reference system using polar coordinates with origin at a point 69% along a long axis from the anterior aspect of the aortic valve to the apex at end systole. (Interestingly, this long axis was recently [and independentlyl shown by Brower et al.' to allow the most precise localization of the ventriculographic apex by objective criteria.)
We did not claim that the method we defined was optimum for measuring endocardial motion by angiography or echocardiography. In fact, in an attempt to demonstrate the uncoupling of these two types of motion we pointed out (in table 3) that the motions of midwall markers and adjacent dye borders were not well correlated.
Very recently, however, we have tested our new measurement method in a clinical setting using ventriculograms from 65 patients; 28 normals with no evidence of ventricular dysfunction, 19 with documented isolated anterior myocardial infarction, and 18 with documented isolated inferior myocardial infarction (unpublished data). We found that our new method performed better than the other methods tested in separating these clinical groups. Similarly, Karsch et al.2 recently published a comparison of 19 methods for analyzing left ventriculographic dye border motion and concluded that the best method they tested (they did not test our method) used a fixed external reference system with origin at the midpoint of a long axis defined from the aortic valve to the apex at end systole. This is very similar to our approach.
Thus, there is a growing body of evidence that the best present method to measure ventricular wall motion and dye or echo border motion is to use a fixed external reference system with polar origin near the center of an end systolic long axis. This method is simple to use manually or to implement on a computer and is in routine use in the Cardiac Catheterization Laboratory at Stanford University Medical Center. 3 We paid a great deal of attention to the problem raised by Dr. Gelbert's second question in our 1975 paper describing marker method.4 Using biplane cineradiograms we measured the angular rotation of three principal transverse axes and found that, while the heart does indeed rotate in systole, rotation out of the RAO plane contributes a mean error in measurement of transverse axis shortening of only 1.2%. We have recently repeated this work in our laboratory with identical results. Thus the rotation artifact exists, but it is of little consequence in the present study.
Thromboxane A2 Release and the Injury-Spasm Hypothesis
To the Editor:
read with interest the study of Lewy et al.,' which demonstrated release of vasoconstricting thromboxane A2 with atrial pacing. This suggested "a more complex circulatory response to ischemia than vasodilation alone." VOL 62, No 3, SEPTEMBER 1980 This study supports the injury-spasm concept,2' which asserts that severe ischemia can cause spasm of small mural arteries as a response to tissue injury. It is assumed that the injury-spasm reaction can overcome the normal reactive hyperemic response to ischemia and the balance of vasoconstrictive/vasodilative forces determines if spasm occurs or remits. Spasm of epicardial arteries is regarded as a secondary or concomitant event. Because of the view that spasm plays a central role in ischemic heart disease, positions were adopted which then were either isolated or scantily endorsed, and which later received other support. These include the spastic causes of unstable' and effort6 angina, infarction,7 8 coronary artery thrombosis,8 and possibly even coronary artery disease."
An important consideration is that the injury-spasm viewpoint is incompatible with relative insufficiency. This latter mechanism had been accepted as the explanation for ischemic heart disease, and assumes that ischemia causes symptoms directly and that small arteries always dilate to compensate for reduced blood flow (dilatory reserve).
In spite of the almost automatic assumption that severe ischemia invariably causes vasodilation, there is experimental evidence that severe ischemia can cause spasm in mural coronary'" 11 and cerebral"'2 13 arteries, and induce constriction of isolated coronary artery strips.'4 Also, the vasodilating prostaglandin prostacyclin markedly improves blood flow in peripheral vascular disease,'`and this is in keeping with reversal of vasoconstriction of the vascular bed. assume thromboxane A, was released after atrial pacing' to mediate the vasoconstrictive injury-spasm response. Mediators of vasomotion of small arteries include the several prostaglandins, and adrenergic and neural factors, and spasm secondary to severe ischemia has been prevented by prostaglandin inhibition," neural interruption,"0 and 13-adrenergic blockade" (probably due to paradoxic blockade of vasoconstrictive adrenergic sites',). This line of reasoning suggests that the beneficial action of prostaglandin inhibition in preventing myocardial infarction and strokes might be directed to blocking the vasoconstrictive response to severe ischemia rather than preventing release of vasoconstrictors from platelets.
The newer information which is in favor of the injury-spasm position has also permitted its consolidation. In a separate communication, I plan to redefine the hypothesis as a basic homeostatic response and discuss its relationship to prostaglandins and platelets in detail.
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